Bavencio


What it is used for

BAVENCIO is indicated for the treatment of adults and paediatric patients 12 years and older with metastatic Merkel Cell Carcinoma (mMCC).,This indication is approved based on tumour response rate, duration of response in a single arm study.


How to take it

The way to take this medicine is: Intravenous Infusion.

  • Store at 2 to 8 degrees Celsius
  • Refrigerate
  • Do not Freeze
  • Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Reporting side effects

This medicine is under additional monitoring as it is new or being used in a different way. You can help identify new safety information by reporting any side effects you may get.

  • You can report side effects to your doctor, or directly at www.tga.gov.au/reporting-problems.
  • For more information on the Black Triangle Scheme and how to report side effects, see www.tga.gov.au/black-triangle-scheme

How to take it

The way to take this medicine is: Intravenous Infusion.

  • Store at 2 to 8 degrees Celsius
  • Refrigerate
  • Do not Freeze
  • Shelf lifetime is 24 Months.

You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.

Always read the label. If symptoms persist see your healthcare professional.


Pregnant or planning a pregnancy?

For the active ingredient avelumab

You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.


Do I need a prescription?

This medicine is available from a pharmacist and requires a prescription. It is Schedule 4 : Prescription Only Medicine.


Visual appearance

Clear, colourless to slightly yellow solution

0 0 votes
Do you use this medicine? Rate it:
Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments